Back to Search
Start Over
Reply to the article 'Editorial comments on 'reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study'', by P. A. Bunn Jr (Ann Oncol 2001; 12: 1339-1340)
- Source :
- Annals of Oncology, 13, 3, pp. 485-486, Annals of Oncology, 13, 485-486
- Publication Year :
- 2002
-
Abstract
- Item does not contain fulltext
- Subjects :
- medicine.medical_specialty
Lung Neoplasms
Neutropenia
Fever
Placebo
Gastroenterology
Double blind
Experimental diagnostics and therapy of malignancies
Chemotherapy induced
Double-Blind Method
Ciprofloxacin
Internal medicine
Antineoplastic Combined Chemotherapy Protocols
Medicine
Humans
Carcinoma, Small Cell
Cyclophosphamide
Etoposide
Randomized Controlled Trials as Topic
Roxithromycin
Febrile leucopenia
business.industry
Palliative Care
Hematology
Antibiotic Prophylaxis
Surgery
Oncology
Clinical Trials, Phase III as Topic
Doxorubicin
Drug Therapy, Combination
Non small cell
business
medicine.drug
Subjects
Details
- ISSN :
- 09237534
- Volume :
- 13
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Annals of oncology : official journal of the European Society for Medical Oncology
- Accession number :
- edsair.doi.dedup.....946af8b160387f8e4500a311db7da184